Literature DB >> 25325880

Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: results from the KORA F4 study.

Christian Herder1, Brenda W C Bongaerts2, Wolfgang Rathmann2, Margit Heier3, Bernd Kowall2, Wolfgang Koenig4, Barbara Thorand5, Michael Roden6, Christa Meisinger3, Dan Ziegler6.   

Abstract

OBJECTIVE: Inflammatory processes have been implicated in the pathogenesis of painful neuropathy in rodents, but the relationship between inflammatory biomarkers and painful distal sensorimotor polyneuropathy (DSPN) has not been assessed in population-based studies. Therefore, we investigated whether circulating levels of seven pro- and anti-inflammatory immune mediators were associated with painful DSPN in older individuals in a large population-based study. RESEARCH DESIGN AND METHODS: The study population consisted of individuals with painless (n = 337) and painful DSPN (n = 54) from a source population (n = 1,047) of men and women aged 61-82 years who participated in the German KORA F4 survey (2006-2008). We measured circulating levels of seven immune mediators and assessed their associations with the presence of painful DSPN using multiple logistic regression models.
RESULTS: After adjustment for age and sex, we found positive associations between serum concentrations of the cytokine interleukin (IL)-6 and the soluble intercellular adhesion molecule (sICAM)-1 and painful DSPN (P = 0.004 and P = 0.005, respectively), whereas no associations were observed for C-reactive protein, IL-18, tumor necrosis factor-α, adiponectin, and IL-1 receptor antagonist (IL-1RA, P = 0.07-0.38). Associations between IL-6 and sICAM-1 and painful DSPN remained significant after additional adjustment for waist circumference, height, hypertension, cholesterol, smoking, alcohol intake, physical activity, history of myocardial infarction and/or stroke, presence of other neurological conditions, and use of nonsteroidal anti-inflammatory drugs (P = 0.005 and P = 0.016, respectively).
CONCLUSIONS: Painful DSPN is linked to systemic subclinical and vascular inflammation in the older population independent of anthropometric, lifestyle, and metabolic confounders.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25325880     DOI: 10.2337/dc14-1403

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

Review 1.  Systemic inflammatory response after hernia repair: a systematic review.

Authors:  Dunja Kokotovic; Jakob Burcharth; Frederik Helgstrand; Ismail Gögenur
Journal:  Langenbecks Arch Surg       Date:  2017-08-22       Impact factor: 3.445

2.  Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice.

Authors:  Phillipe D O'Brien; Lucy M Hinder; Sebastian D Parlee; John M Hayes; Carey Backus; Hongyu Zhang; Lijun Ma; Stacey A Sakowski; Frank C Brosius; Eva L Feldman
Journal:  Diabetes Obes Metab       Date:  2017-06-02       Impact factor: 6.577

Review 3.  Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.

Authors:  Gordon Sloan; Dinesh Selvarajah; Solomon Tesfaye
Journal:  Nat Rev Endocrinol       Date:  2021-05-28       Impact factor: 43.330

Review 4.  Association Between Tumor Necrosis Factor-α and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: a Meta-Analysis.

Authors:  Ze-Peng Mu; Yan-Gang Wang; Cheng-Qian Li; Wen-Shan Lv; Bin Wang; Zhao-Hai Jing; Xue-Jia Song; Yu Lun; Ming-Yue Qiu; Xiao-Long Ma
Journal:  Mol Neurobiol       Date:  2016-01-21       Impact factor: 5.590

Review 5.  Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015.

Authors:  Nikolaos Papanas; Dan Ziegler
Journal:  Rev Diabet Stud       Date:  2015-08-10

6.  The Association between Serum Cytokines and Damage to Large and Small Nerve Fibers in Diabetic Peripheral Neuropathy.

Authors:  Francesca Magrinelli; Chiara Briani; Marcello Romano; Susanna Ruggero; Elisabetta Toffanin; Giuseppa Triolo; George Chummar Peter; Marialuigia Praitano; Matteo Francesco Lauriola; Giampietro Zanette; Stefano Tamburin
Journal:  J Diabetes Res       Date:  2015-04-16       Impact factor: 4.011

7.  Long-term study of the association of adipokines and glucose variability with diabetic complications.

Authors:  Jin Joo Cha; Hye Sook Min; Kitae Kim; Mi Jin Lee; Mi Hwa Lee; Jung Eun Kim; Hye Kyoung Song; Dae Ryong Cha; Young Sun Kang
Journal:  Korean J Intern Med       Date:  2016-11-04       Impact factor: 2.884

Review 8.  Painful and Painless Diabetic Neuropathies: What Is the Difference?

Authors:  Pallai Shillo; Gordon Sloan; Marni Greig; Leanne Hunt; Dinesh Selvarajah; Jackie Elliott; Rajiv Gandhi; Iain D Wilkinson; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2019-05-07       Impact factor: 4.810

9.  Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.

Authors:  Dan Ziegler; Alexander Strom; Gidon J Bönhof; Julia M Kannenberg; Margit Heier; Wolfgang Rathmann; Annette Peters; Christina Meisinger; Michael Roden; Barbara Thorand; Christian Herder
Journal:  BMJ Open Diabetes Res Care       Date:  2019-11-27

10.  Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 study.

Authors:  Cornelia Then; Christian Herder; Holger Then; Barbara Thorand; Cornelia Huth; Margit Heier; Christa Meisinger; Annette Peters; Wolfgang Koenig; Wolfgang Rathmann; Michael Roden; Michael Stumvoll; Haifa Maalmi; Thomas Meitinger; Andreas Lechner; Jürgen Scherberich; Jochen Seissler
Journal:  Clin Kidney J       Date:  2020-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.